Effects of erythropoiesis-stimulating agents on overall survival of International Prognostic Scoring System Low/Intermediate-1 risk, transfusion-independent myelodysplastic syndrome patients: a cohort study

類似資料

• Are somatic mutations predictive of response to erythropoiesis stimulating agents in lower risk myelodysplastic syndromes?
  著者:: Olivier Kosmider, 等
  出版事項: (2016-07-01)
• Iron Chelation Therapy in Myelodysplastic Syndromes
  著者:: Emanuela Messa, 等
  出版事項: (2010-01-01)
• Molecular mechanisms of regulation of erythropoiesis and stress erythropoiesis
  著者:: Momčilović Sanja, 等
  出版事項: (2024-01-01)
• The role of glucocorticoids in erythropoiesis
  著者:: Lars L. P. Hanssen, 等
  出版事項: (2025-02-01)
• A correlation of ineffective erythropoiesis and dysregulated signaling pathways in myelodysplastic syndromes/neoplasms
  著者:: Junying Wu, 等
  出版事項: (2025-05-01)